Trulieve CEO Kim Rivers to Present at Cannabis Investor Day at OTC Markets Group

Photo_Asset_1

TORONTO, Oct. 28, 2019 /CNW/ - Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced that CEO Kim Rivers will deliver a presentation on the Company at the OTC Markets Group & Canadian Securities Exchange's Cannabis Investor Day, being held on Wednesday, October 30, 2019 in New York City. This one-day event will bring together cannabis investors, market operators, industry experts, and C-suite level executives.

Trulieve (CNW Group/Trulieve Cannabis Corp.)

This sold-out conference will also be livestreamed and can be viewed through the Trulieve Investor Relations site.

About Trulieve

Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

To learn more about Trulieve, visit www.Trulieve.com.

The Canadian Securities Exchange has not reviewed, approved or disapproved the ‎content of this news release.‎

SOURCE Trulieve Cannabis Corp.

For further information: Lynn Ricci, Director of Investor Relations, 1-850-270-5691, lynn.ricci@trulieve.com